Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$24k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
7
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
8
users have liked this narrative
1
users have commented on this narrative
16
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
9
users have liked this narrative
2
users have commented on this narrative
13
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Cytosorbents
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Healthcare Pricing And Regulation Will Stunt Prospects Despite Slight Hope
Key Takeaways Heavy dependence on a single product and slow pipeline diversification heightens vulnerability to competition, market shifts, and regulatory setbacks. Cost containment, payer leverage, and changing medical practices threaten pricing power, core market growth, and long-term profitability.
View narrative
US$1.00
FV
8.0% overvalued
intrinsic discount
18.82%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
PodcastOne
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Podcast Consolidation Will Limit Revenue While Small Recovery Unfolds
Key Takeaways Heavy competition and industry consolidation by tech giants limit PodcastOne's revenue growth and negotiating power, despite increased digital audio consumption and advertising opportunities. Rising content costs, stricter privacy rules, and audience fragmentation threaten profit margins and make sustained growth or market share gains increasingly difficult.
View narrative
US$3.75
FV
57.3% undervalued
intrinsic discount
15.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Tigo Energy
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Debt And Regulation Will Test Solar Integration But Enable Rebound
Key Takeaways Reliance on a focused MLPE product line and supply chain vulnerabilities expose the company to technology risk, market shifts, and margin pressures. High R&D spending and upcoming debt refinancing amid competitive and regulatory challenges could constrain profitability and international expansion.
View narrative
US$3.00
FV
57.0% undervalued
intrinsic discount
34.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Mister Spex
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Macroeconomic Headwinds Will Derail Eyewear Recovery
Key Takeaways Intensifying competitive and regulatory pressures threaten Mister Spex's profitability, with rising costs, margin compression, and compliance challenges. Changing consumer preferences and digital marketing saturation risk market share loss and reduced effectiveness of growth initiatives.
View narrative
€1.40
FV
34.6% overvalued
intrinsic discount
-2.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Surf Air Mobility
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Delayed Hybrid Certification And EAS Dependence Will Weaken Outlook
Key Takeaways Reliance on uncertain regulatory approval and government contracts exposes the business to high operational risk and revenue instability. Unproven digital offerings, persistent losses, and intensifying competition signal ongoing profitability challenges and limited growth visibility.
View narrative
US$3.00
FV
40.0% overvalued
intrinsic discount
18.70%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Verrica Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 2 Analysts
Restrictive Payer Policies Will Limit Dermatology Revenues But Spur Recovery
Key Takeaways Heightened reimbursement restrictions and regulatory scrutiny may limit market expansion and erode pricing power, increasing revenue and margin volatility. Heavy dependence on a single key product, combined with funding pressures and pipeline delays, threatens long-term earnings growth and financial stability.
View narrative
US$20.00
FV
69.8% undervalued
intrinsic discount
101.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Inuvo
AN
AnalystLowTarget
Consensus Narrative from 4 Analysts
Tight Privacy Rules Will Hinder Progress Yet AI Offers Hope
Key Takeaways IntentKey's privacy-first and AI strengths face challenges from evolving regulations, browser policies, and limited brand reach, threatening scalable growth and market share gains. Dependency on concentrated partners and rising investment needs, combined with historic operating losses, hinder scalable profitability despite operational improvements and expanding advertising markets.
View narrative
US$10.00
FV
64.6% undervalued
intrinsic discount
12.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
U.S. Energy
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Evolving Renewables Will Pressure Legacy Energy Yet Spark Niche Potential
Key Takeaways Rapid renewable adoption, regulatory uncertainty, and ESG focus threaten long-term revenue growth, net margins, and access to capital for U.S. Energy. Smaller scale and high commodity exposure limit U.S. Energy's ability to fully benefit from industry trends and increase cash flow predictability.
View narrative
US$2.00
FV
40.5% undervalued
intrinsic discount
13.39%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Owlet
AN
AnalystLowTarget
Consensus Narrative from 5 Analysts
Regulation And Tariffs Will Hinder Digital Health Yet Spur Recovery
Key Takeaways Regulatory and demographic headwinds may constrain market growth, pressure margins, and increase compliance costs for pediatric monitoring products. Competitive threats and consumer skepticism could limit recurring revenues, despite innovation, product adoption, and efforts to expand reimbursement streams.
View narrative
US$11.00
FV
33.5% undervalued
intrinsic discount
18.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Value any company in seconds
Popular companies